CVS Health Operating Segments — Revenue decreased by 5.0% to $100.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $94.59B to $100.43B. Over 4 years (FY 2021 to FY 2025), Operating Segments — Revenue shows an upward trend with a 8.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher demand for the segment's products, while a decrease may signal competitive pressure or market contraction.
This represents the total gross inflow of economic benefits arising from the ordinary operating activities of a specific...
Standard across all public companies as 'Segment Revenue' or 'Net Sales by Segment'.
cvs_segment_operating_segments_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.62B | $73.79B | $76.60B | $76.83B | $80.64B | $81.16B | $83.85B | $85.28B | $88.92B | $89.76B | $93.81B | $88.44B | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B |
| QoQ Change | — | +1.6% | +3.8% | +0.3% | +5.0% | +0.6% | +3.3% | +1.7% | +4.3% | +0.9% | +4.5% | -5.7% | +3.2% | +4.6% | +2.4% | -3.2% | +4.6% | +4.0% | +2.7% | -5.0% |
| YoY Change | — | — | — | — | +11.0% | +10.0% | +9.5% | +11.0% | +10.3% | +10.6% | +11.9% | +3.7% | +2.6% | +6.3% | +4.2% | +7.0% | +8.4% | +7.8% | +8.2% | +6.2% |